Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 2011, 902674

CpG Island Methylation in Colorectal Cancer: Past, Present and Future

Affiliations

CpG Island Methylation in Colorectal Cancer: Past, Present and Future

Karen Curtin et al. Patholog Res Int.

Abstract

The concept of a CpG island methylator phenotype, or CIMP, quickly became the focus of several colorectal cancer studies describing its clinical and pathological features after its introduction in 1999 by Toyota and colleagues. Further characterization of CIMP in tumors lead to widespread acceptance of the concept, as expressed by Shen and Issa in their 2005 editorial, "CIMP, at last." Since that time, extensive research efforts have brought great insights into the epidemiology and prognosis of CIMP+ tumors and other epigenetic mechanisms underlying tumorigenesis. With the advances in technology and subsequent cataloging of the human methylome in cancer and normal tissue, new directions in research to understand CIMP and its role in complex biological systems yield hope for future epigenetically based diagnostics and treatments.

Figures

Figure 1
Figure 1
In colorectal cancer, CIMP+ occurs more frequently in tumors of the proximal colon (Figure 1(a)) and less frequently in tumors of the distal colon and rectum (Figure 1(b)). An approximate distribution of genetic and epigenetic tumor alterations is shown.
Figure 2
Figure 2
A decade of epigenetic research in colorectal cancer (CRC) has led to widespread recognition and acceptance of the CpG Island Methylator Phenotype.

Similar articles

See all similar articles

Cited by 74 articles

See all "Cited by" articles

References

    1. Bonasio R, Tu S, Reinberg D. Molecular signals of epigenetic states. Science. 2010;330(6004):612–616. - PMC - PubMed
    1. Esteller M. Molecular origins of cancer: epigenetics in cancer. New England Journal of Medicine. 2008;358(11):1148–1096. - PubMed
    1. Feinberg AP, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature. 1983;301(5895):89–92. - PubMed
    1. Greger V, Passarge E, Hopping W, Messmer E, Horsthemke B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma. Human Genetics. 1989;83(2):155–158. - PubMed
    1. Lujambio A, Ropero S, Ballestar E, et al. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Cancer Research. 2007;67(4):1424–1429. - PubMed

LinkOut - more resources

Feedback